Interleukin Genetics Inc

Type: Company
Name: Interleukin Genetics Inc
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Interleukin Genetics Publishes Additional Evidence for the PerioPredict™ Genetic Risk Test in Journal of Periodontal Research

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced the pre-print online publication of its research study titled “Association of interleukin-1 gene variations with moderate to severe chronic periodontitis in multiple ... [Published Business Wire Health News - Apr 11 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

INTERLEUKIN GENETICS : Announces Changes to Its Board of Directors

By a News Reporter-Staff News Editor at Health & Medicine Week -- Interleukin Genetics, Inc. (OTCQB:ILIU) announced several changes to the Company's Board of Directors. Joseph Landstra , Director of Finance at Alticor Corporate Enterprises , will join ... [Published 4 Traders - Apr 10 2014]
First reported Apr 06 2014 - Updated Apr 06 2014 - 1 reports

SmallCapNewsRelease: (OTCBB:HBSY) Becomes the Exclusive...

San West, Inc. (OTCBB:HBSY-NEWS) announced today that, through a letter of intent, it will be the exclusive distributor of TrophyKart products in San Diego County.The agreement between TrophyKart and San West is estimated to bring in revenues upward of ... [Published Free Press Release - Apr 06 2014]
First reported Mar 31 2014 - Updated Apr 01 2014 - 3 reports

INTERLEUKIN GENETICS ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

INTERLEUKIN GENETICS ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS ... [Published Noodls - Apr 01 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Interleukin Genetics Q4 net loss increases

Interleukin Genetics, Inc., which is engaged in developing and commercializing personalized health products, has reported that net loss for the fourth quarter ended December 31, 2013 was $1.9 million, or $0.02 loss per share, compared to a net loss of ... [Published Individual.com - Mar 26 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Interleukin Genetics Posts Fourth Quarter and Year-End 2013 Financial Results

Interleukin Genetics issued financial and operational results for its fiscal fourth quarter and full fiscal year ended December 31, 2013. "Interleukin Genetics achieved a number of important milestones in 2013, including the introduction and launch of ... [Published Individual.com - Mar 25 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

Interleukin Genetics, Given Outperform Rating at Zacks (ILIU)

Zacks’ analyst wrote, “Key UofM PST (periodontal disease) test study results were overwhelmingly positive and published in June 2013. Dental plans are now covering cost of test. PerioPredict launched in early 2014 and indications are that it is meeting ... [Published American Banking News - Forex - Mar 21 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

Interleukin Genetics CEO Discusses Q4 2013 Results - Earnings Call Transcript

Interleukin Genetics, Inc. ( OTCQB:ILIU ) Q4 2013 Results Earnings Conference Call March 20, 2014 4:30 PM ETOperatorGood day ladies and gentlemen and thank you for standing by, and welcome to the Interleukin Genetics, 2013 fourth quarter and year end ... [Published Seeking Alpha - Mar 21 2014]
First reported Mar 20 2014 - Updated Mar 20 2014 - 4 reports

Interleukin Genetics EPS -$0.02

Interleukin Genetics, Inc. ( OTCQB:ILIU ): Q4 EPS of -$0.02Revenue of $671K Post your comment! ... [Published Seeking Alpha - Mar 20 2014]
First reported Mar 18 2014 - Updated Mar 18 2014 - 2 reports

Interleukin Genetics Introduces Periopredict™

For Immediate ReleaseNovember 25, 2013WALTHAM, Mass., — Interleukin Genetics, Inc. (OTCQB: ILIU) today announced the introduction of PerioPredict™, the Company's new, next-generation version of the PST® genetic risk test for periodontal disease. PerioPredict™ ... [Published Bay City Capital - Mar 18 2014]
First reported Mar 17 2014 - Updated Mar 18 2014 - 1 reports

INTERLEUKIN GENETICS : Change in Directors or Principal Officers (form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election Of Directors;Appointment of Certain Officers; Compensatory Arrangements of CertainOfficers.(b) On March 11, 2014 , James Weaver , Chairman of the Board of Directors ofInterleukin Genetics, ... [Published 4 Traders - Mar 17 2014]
First reported Mar 13 2014 - Updated Mar 13 2014 - 1 reports

Interleukin Genetics, Inc. Announces Conference Call to Discuss Fourth Quarter 2013 Results

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and Webcast on Thursday, March 20, 2014 at 4:30 p.m. (ET) to provide a corporate update and discuss the Company’s fourth quarter ... [Published Business Wire Health News - Mar 13 2014]

Quotes

...Kenneth Kornman , Chief Executive Officer of Interleukin Genetics . "We thank Goran for his contributions and service to Interleukin during the last two years, and we will continue our work with Delta Dental through our launch of PerioPredict™. We look forward to Jim's continued leadership and guidance and welcome Joe's contributions as we enter a very exciting and transformative time in our development as a company."
...43 million, compared to $2.24 million for the year ended December 31, 2012. Kenneth Kornman, CEO of Interleukin Genetics, said: "Interleukin Genetics achieved a number of important milestones in 2013, including the introduction and launch of PerioPredict, our new generation of genetic risk assessment test for severe periodontal disease."
Dr. Kornman continued: "The upgraded automation of our CLIA-certified laboratory is fully operational, and we have begun receiving patient samples for testing. We are also fully prepared for the additional capacity we are expecting from the next phases of the launch. Our marketing team is in the field actively educating dental offices about how to use the PerioPredict test to enhance dental preventive care. Clearly, this is an exciting time for the Company, and we look forward to communicating our progress throughout the year."
...Kenneth Kornman, Chief Executive Officer of Interleukin Genetics. "We are actively preparing for the formal launch in January 2014 and our CLIA-certified lab stands ready to receive and process patient samples. Over the long term, we believe that PerioPredict™ offers the potential to improve outcomes for dental patients and ultimately reduce long-term oral healthcare expenses."

More Content

All (22) | News (18) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Interleukin Genetics Publishes Additional Evide... [Published Business Wire Health News - Apr 11 2014]
INTERLEUKIN GENETICS : Announces Changes to Its... [Published 4 Traders - Apr 10 2014]
SmallCapNewsRelease: (OTCBB:HBSY) Becomes the E... [Published Free Press Release - Apr 06 2014]
INTERLEUKIN GENETICS ANNOUNCES CHANGES TO ITS B... [Published Noodls - Apr 01 2014]
Interleukin Genetics Announces Changes to Its B... [Published 4 Traders - Mar 31 2014]
Interleukin Genetics Announces Changes to Its B... [Published Business Wire Health News - Mar 31 2014]
Interleukin Genetics Q4 net loss increases [Published Individual.com - Mar 26 2014]
Interleukin Genetics Posts Fourth Quarter and Y... [Published Individual.com - Mar 25 2014]
Interleukin Genetics, Given Outperform Rating a... [Published American Banking News - Forex - Mar 21 2014]
Interleukin Genetics CEO Discusses Q4 2013 Resu... [Published Seeking Alpha - Mar 21 2014]
Interleukin Genetics EPS -$0.02 [Published Seeking Alpha - Mar 20 2014]
Interleukin Genetics Reports Fourth Quarter and... [Published HispanicBusiness.com - Mar 20 2014]
Interleukin Genetics Reports Fourth Quarter and... [Published Investor's Business Daily - Mar 20 2014]
Interleukin Genetics Reports Fourth Quarter and... [Published Business Wire Health News - Mar 20 2014]
INTERLEUKIN GENETICS : Management's Discussion ... [Published 4 Traders - Mar 20 2014]
After-Hours Earnings Report for March 20, 2014 ... [Published Nasdaq - Mar 20 2014]
Interleukin Genetics Introduces Periopredict™ [Published Bay City Capital - Mar 18 2014]
Interleukin Genetics : Announces Conference Cal... [Published 4 Traders - Mar 18 2014]
INTERLEUKIN GENETICS : Change in Directors or P... [Published 4 Traders - Mar 17 2014]
Interleukin Genetics, Inc. Announces Conference... [Published Business Wire Health News - Mar 13 2014]
Myriad Genetics, Inc. - Mergers & Acquisitions ... [Published SBWire - Mar 13 2014]
DNA-Based Dieting More Than Doubles Weight Loss... [Published PRWeb - Feb 10 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Interleukin Genetics Publishes Additional Evide... [Published Business Wire Health News - Apr 11 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced the pre-print online publication of its research study titled “Association of interleukin-1 gene variations with moderate to severe chronic periodontitis in multiple ...
Interleukin Genetics Announces Changes to Its B... [Published Business Wire Health News - Mar 31 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced several changes to the Company’s Board of Directors. Joseph Landstra, Director of Finance at Alticor Corporate Enterprises, will join the Board as a Director, filling ...
Interleukin Genetics Reports Fourth Quarter and... [Published Business Wire Health News - Mar 20 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal fourth quarter and full fiscal year ended December 31, 2013. “Interleukin Genetics achieved a number of important milestones ...
Interleukin Genetics, Inc. Announces Conference... [Published Business Wire Health News - Mar 13 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and Webcast on Thursday, March 20, 2014 at 4:30 p.m. (ET) to provide a corporate update and discuss the Company’s fourth quarter ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.